Moderated by: Nazia Selzner & James Pomposelli

Targeting Tumoral Fatty Acid Desaturase 1 Empower IL-15-Armed GPC3-CAR-T Therapy in Hepatocellular Carcinoma
Tao Ding

Clinical Features and Long-Term Outcomes of Patients with Complete Immunosuppression Withdrawal After Liver Transplantation: A Multicentre, Worldwide Study
Young Investigator Award Recipient: Roberta Angelico

Non-Vascular, Non-Cirrhotic Portal Hypertension Following Liver Transplantation Is Largely Caused by Combination of Portosinusoidal Injury and Allograft Rejection
Young Investigator Award Recipient: Iulia Minciuna

Auxiliary Partial Orthotopic Liver Transplantation Provides Durable Recovery in Pediatric Fulminant Hepatic Failure: Multicenter Experience in Children <10 Years
Tomoaki Kato

Towards Time-Unlimited Liver Preservation: Key Steps in Advancing Long-Term Ex Vivo Normothermic Machine Perfusion from Days to 7 Weeks
Daniel Babekuhl

From National Policy to Clinical Practice: Early Experience with a Structured Prehabilitation and Rehabilitation Pathway in Liver Transplantation
Diethard Monbaliu

Off-the-Shelf CAR-T Cells Resistant to Immunosuppression for Cancer Therapy in Transplant Recipients
Young Investigator Award Recipient: Xinyang Zhong